Literature DB >> 23052898

[Guidelines-oriented diagnostics of dyslipidemia].

T Kaiser1, J Thiery.   

Abstract

Cardiovascular diseases are the main cause of mortality for patients with advanced age. Changes in lipid metabolism are common and play an important role as key risk factors. This article explains an approach in the diagnostics of dyslipidemia according to the current guidelines. First, the overall risk evaluation of cardiovascular mortality based on the current chart has to be evaluated. Depending on these results an individual LDL-C goal should be defined. The article also includes other relevant cardiovascular risk factors which were not included in the established risk charts. Furthermore, the main innovative biomarkers are discussed in their possible applications and diagnostic value.

Entities:  

Mesh:

Year:  2012        PMID: 23052898     DOI: 10.1007/s00059-012-3683-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  21 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

Review 2.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Authors:  Giovanni F M Strippoli; Sankar D Navaneethan; David W Johnson; Vlado Perkovic; Fabio Pellegrini; Antonio Nicolucci; Jonathan C Craig
Journal:  BMJ       Date:  2008-02-25

3.  Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Authors:  Daniel H Solomon; Elizabeth W Karlson; Eric B Rimm; Carolyn C Cannuscio; Lisa A Mandl; JoAnn E Manson; Meir J Stampfer; Gary C Curhan
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

Review 6.  Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Authors:  Carolina A Garza; Victor M Montori; Joseph P McConnell; Virend K Somers; Iftikhar J Kullo; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2007-02       Impact factor: 7.616

7.  The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

Authors:  Thomas Almdal; Henrik Scharling; Jan Skov Jensen; Henrik Vestergaard
Journal:  Arch Intern Med       Date:  2004-07-12

8.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

Review 9.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

10.  Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.

Authors:  Peter S Sever; Neil R Poulter; Choon L Chang; Aroon Hingorani; Simon A Thom; Alun D Hughes; Paul Welsh; Naveed Sattar
Journal:  Eur Heart J       Date:  2011-07-28       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.